Predictors of loss due to pharmaceutical fraud: evidence from the U.S.

Yuriy Timofeyev Susan A Hayes Mihajlo Michael Jakovljevic

Published in: Cost effectiveness and resource allocation : C/E (2022)

This study empirically justifies considering loss, due to pharmaceutical fraud, from a multi-level perspective. Identified profiles of a typical fraudster helped to elaborate on specific practical recommendations aimed at pharmaceutical fraud prevention in the U.S.

Keyphrases